Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Rodondi

Showing results (31-40 of 531) with videos related to

Pageof 54
Sort By:
Revue Medicale Suisse|December 18, 2015
[Successful prevention: communication or negotiation art?]Gérard Waeber, Bertrand Kiefer, Nicolas Rodondi
The Lancet. Public Health|February 8, 2020
High-value, data-informed, and team-based care for multimorbidityArnaud Chiolero, Nicolas Rodondi, Valérie Santschi
Swiss Medical Weekly|November 24, 2016
New concepts in the management of dyslipidaemiaaBaris Gencer, Nicolas Rodondi, Francois Mach
The American Journal of Medicine|December 21, 2020
The ReplyBaris Gencer, Douglas C Bauer, Nicolas Rodondi
Praxis|May 7, 2013
[Dyslipidemia - when are lipid lowering medications useful in clinical practice?]Manuel R Blum, Zeno Stanga, Nicolas Rodondi
Comprehensive Therapy|August 20, 2005
Aspirin for the primary prevention of cardiovascular disease: a comprehensive reviewNicolas Rodondi, Jacques Cornuz, Douglas C Bauer
Swiss Medical Weekly|December 24, 2014
Subclinical hypothyroidism: summary of evidence in 2014Christine Baumgartner, Manuel R Blum, Nicolas Rodondi
BMJ Open|December 22, 2022
Barriers and facilitators to deprescribing of cardiovascular medications: a systematic reviewLaureline Brunner, Nicolas Rodondi, Carole Elodie Aubert
JAMA|February 27, 2019
Thyroid Hormone Therapy for Subclinical Hypothyroidism-ReplyMartin Feller, Nicolas Rodondi, Olaf M Dekkers
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 10, 2016
Response to Tomoyuki Kawada, MD: Smoking, Systolic Blood Pressure, Fasting Plasma Glucose and Progression of Carotid AtherosclerosisSarah Zingg, Tinh-Hai Collet, Nicolas Rodondi
Pageof 54

Showing results (31-40 of 531) with videos related to

Sort By:
Pageof 54
Revue Medicale Suisse|December 18, 2015
[Successful prevention: communication or negotiation art?]Gérard Waeber, Bertrand Kiefer, Nicolas Rodondi
The Lancet. Public Health|February 8, 2020
High-value, data-informed, and team-based care for multimorbidityArnaud Chiolero, Nicolas Rodondi, Valérie Santschi
Swiss Medical Weekly|November 24, 2016
New concepts in the management of dyslipidaemiaaBaris Gencer, Nicolas Rodondi, Francois Mach
The American Journal of Medicine|December 21, 2020
The ReplyBaris Gencer, Douglas C Bauer, Nicolas Rodondi
Praxis|May 7, 2013
[Dyslipidemia - when are lipid lowering medications useful in clinical practice?]Manuel R Blum, Zeno Stanga, Nicolas Rodondi
Comprehensive Therapy|August 20, 2005
Aspirin for the primary prevention of cardiovascular disease: a comprehensive reviewNicolas Rodondi, Jacques Cornuz, Douglas C Bauer
Swiss Medical Weekly|December 24, 2014
Subclinical hypothyroidism: summary of evidence in 2014Christine Baumgartner, Manuel R Blum, Nicolas Rodondi
BMJ Open|December 22, 2022
Barriers and facilitators to deprescribing of cardiovascular medications: a systematic reviewLaureline Brunner, Nicolas Rodondi, Carole Elodie Aubert
JAMA|February 27, 2019
Thyroid Hormone Therapy for Subclinical Hypothyroidism-ReplyMartin Feller, Nicolas Rodondi, Olaf M Dekkers
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 10, 2016
Response to Tomoyuki Kawada, MD: Smoking, Systolic Blood Pressure, Fasting Plasma Glucose and Progression of Carotid AtherosclerosisSarah Zingg, Tinh-Hai Collet, Nicolas Rodondi
Pageof 54